Biotech HOLDRS (BBH, news, chart, volatility) are trading up $5.50 to $180.30 and volume in the options market is running ten times the usual. 5,870 calls and 0 puts have traded on the fund. Most of the volume appears to be part of bullish spread trading. For example, at 11:36 Eastern Time, 700 of the November 190 calls traded offerside for $3.20 a contract and 700 of the November 200 calls traded bidside for 70 cents.
The pattern was repeated several times across multiple exchanges until volume in both contracts reached 3,500. With very little open interest in either contract, the action appears to be opening bull call spreads. If so, the strategist is paying a $2.50 debit for the opportunity to make $7.50 if BBH, which is a fund that holds Biogen (BIIB), Amgen (AMGN) and a dozen other biotech stocks, rallies to $200 a share or more by November options expiration (52 days).
